SEC 13F Intelligence

Aldebaran Capital, LLC / AMLX

Aldebaran Capital, LLC’s Amylyx Pharmaceuticals Inc Position

Does Aldebaran Capital, LLC own Amylyx Pharmaceuticals Inc (AMLX)? Yes — 197.9K shares worth $3M (+2.10% of its 13F portfolio) as of Q1 2026, down from 198.5K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
197.9K
% of Portfolio
+2.10%
Quarters Held
8
currently held

Position History AMLX

Reported value by quarter
Q2 ’24: $512,626Q2 ’24Q3 ’24: $874,162Q3 ’24Q4 ’24: $993,206Q4 ’24Q1 ’25: $917,756Q1 ’25Q2 ’25: $1MQ2 ’25Q3 ’25: $3MQ3 ’25Q4 ’25: $2MQ4 ’25Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026197.9K$3M+2.10%
Q4 2025198.5K$2M+2.15%
Q3 2025204.5K$3M+2.55%
Q2 2025217.8K$1M+1.38%
Q1 2025259.3K$917,756+0.87%
Q4 2024262.8K$993,206+0.94%
Q3 2024269.8K$874,162+0.80%
Q2 2024269.8K$512,626+0.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aldebaran Capital, LLC’s full portfolio or all institutional holders of AMLX.